9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine
C27H42N8 — CID 117079829
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine
9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine (PubChem CID 117079829) has the molecular formula C27H42N8 and a molecular weight of 478.69 g/mol. Its IUPAC name is 9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine.
Molecular Properties
| Compound Name | 9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine |
|---|---|
| PubChem CID | 117079829 |
| Molecular Formula | C27H42N8 |
| Molecular Weight | 478.69 g/mol |
| Exact Mass | 478.35 |
| IUPAC Name | 9-cyclohexyl-2-N-[3-(dimethylamino)phenyl]-6-N-[2-[di(propan-2-yl)amino]ethyl]purine-2,6-diamine |
| SMILES | CC(C)N(CCNc1nc(Nc2cccc(N(C)C)c2)nc2c1ncn2C1CCCCC1)C(C)C |
| InChI | InChI=1S/C27H42N8/c1-19(2)34(20(3)4)16-15-28-25-24-26(35(18-29-24)22-12-8-7-9-13-22)32-27(31-25)30-21-11-10-14-23(17-21)33(5)6/h10-11,14,17-20,22H,7-9,12-13,15-16H2,1-6H3,(H2,28,30,31,32) |
| InChIKey | IXJRXWDKPZBIKF-UHFFFAOYSA-N |
| XLogP | 5.67 |
| TPSA | 74.14 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 478.69 |
| LogP ≤ 5 | 5.67 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117079829 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.